AboulFotouh K, Allam AA, El-Badry M, El-Sayed AM (2018) Role of self-emulsifying drug delivery systems in optimizing the oral delivery of hydrophilic macromolecules and reducing interindividual variability. Colloids Surf B: Biointerafces 167:82–92

Article  Google Scholar 

Ahmad A, Pepin X, Aarons L, Wang Y, Darwich AS, Wood JM et al (2020) IMI–Oral biopharmaceutics tools project–Evaluation of bottom-up PBPK prediction success part 4: prediction accuracy and software comparisons with improved data and modelling strategies. Eur J Pharm Sci 156:50–63

Google Scholar 

Akgun E, Barbieri MB, Silva JM, Shibu A, Backx BP, Yesilay G et al (2024) Drug-Functionalized nanoparticles for clinical applications. Emerging sustainable nanomaterials for biomedical applications. Springer, pp 409–465

Allam-Ndoul B, Castonguay-Paradis S, Veilleux A (2020) Gut microbiota and intestinal trans-epithelial permeability. Int J Mol Sci 21(17):6402

Article  PubMed  PubMed Central  Google Scholar 

Aminpour M, Montemagno C, Tuszynski JA (2019) An overview of molecular modeling for drug discovery with specific illustrative examples of applications. Molecules 24(9):1693

Article  PubMed  PubMed Central  Google Scholar 

Andrianov AK (2023) Noncovalent pegylation of protein and peptide therapeutics. Wiley Interdisciplinary Reviews: Nanomed Nanobiotechnol 15(5):e1897

Google Scholar 

Anothra P, Pradhan D, Halder J, Ghosh G, Rath G (2023) Gastroretentive drug delivery system in cancer chemotherapy. Curr Drug Deliv 20(5):483–496

Article  PubMed  Google Scholar 

Antimisiaris S, Marazioti A, Kannavou M, Natsaridis E, Gkartziou F, Kogkos G, Mourtas S (2021) Overcoming barriers by local drug delivery with liposomes. Adv Drug Deliv Rev 174:53–86

Article  PubMed  Google Scholar 

Araujo F, Martins C, Azevedo C, Sarmento B (2018) Chemical modification of drug molecules as strategy to reduce interactions with mucus. Adv Drug Deliv Rev 124:98–106

Article  PubMed  Google Scholar 

Arsiccio A, Paladini A, Pattarino F, Pisano R (2019) Designing the optimal formulation for biopharmaceuticals: a new approach combining molecular dynamics and experiments. J Pharm Sci 108(1):431–438

Article  PubMed  Google Scholar 

Ashique S, Garg A, Sirohi E, Kumar S, Mohanalakshmi S, Mishra N (2024) Factors affecting peptide and protein absorption, metabolism, and excretion. In Polysaccharides: Drug Delivery and Utilization, 261-289

Aungst BJ (2012) Absorption enhancers: applications and advances. AAPS J 14(1):10–18

Article  PubMed  Google Scholar 

Baker J, Hidalgo IJ, Borchardt RT (2024) Intestinal epithelial and vascular endothelial barriers to peptide and protein delivery. Peptide and protein drug delivery. CRC, pp 359–390

Balabushevich NG, Pechenkin MA, Shibanova ED, Volodkin DV, Mikhalchik EV (2013) Multifunctional polyelectrolyte microparticles for oral insulin delivery. Macromol Biosci 13(10):1379–1388

Article  PubMed  Google Scholar 

Baral KC, Choi KYJP (2025) Barriers and strategies for oral peptide and protein therapeutics delivery: update on clinical advances. Pharmaceutics 17(4):397

Article  PubMed  PubMed Central  Google Scholar 

Bashyal S, Noh G, Keum T, Choi YW, Lee S (2016) Cell penetrating peptides as an innovative approach for drug delivery: Then, present and the future. J Pharm Invest 46:205–220

Article  Google Scholar 

Beauchesne PR, Chung NS, Wasan KM (2007) Cyclosporine A: a review of current oral and intravenous delivery systems. Drug Dev Ind Pharm 33(3):211–220

Article  PubMed  Google Scholar 

Bektas S, Kaptan E (2024) Lectin-Based targeted drug delivery systems for the treatment of cancer. In: Bektas S, Kaptan E (eds) Interdisciplinary cancer research. Springer, pp 1–16

Beloqui A, Brayden DJ, Artursson P, Préat V,des, Rieux A (2017) A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation. Nature Protocols, 12(7), 1387-1399

Benson SP, Pleiss JL (2014) Molecular dynamics simulations of self-emulsifying drug-delivery systems (SEDDS): influence of excipients on droplet nanostructure and drug localization. Langmuir 30(28):8471–8480

Article  PubMed  Google Scholar 

Berg S, Edlund H, Goundry WR, Bergström CA, Davies NM (2022) Considerations in the developability of peptides for oral administration when formulated together with transient permeation enhancers. Int J Pharm 628:122238

Article  PubMed  Google Scholar 

Binkley N, Bolognese M, Sidorowicz-Bialynicka A, Vally T, Trout R, Miller C, Buben CE, Gilligan JP, Krause DS (2012) (2012). A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial. Journal of Bone and Mineral Research, 27(8), 1821-1829

Biswas M, Nurunnabi M, Khatun Z (2024) Understanding mucosal physiology and rationale of formulation design for improved mucosal immunity. CS Appl Bio Mater 7(8):5037–5056

Article  Google Scholar 

Bojarová P, Křen V (2016) Sugared biomaterial binding lectins: achievements and perspectives. Biomaterials Sci 4(8):1142–1160

Article  Google Scholar 

Bondeson DP, Crews CM (2017) Targeted protein degradation by small molecules. Annu Rev Pharmacol Toxicol 57(1):107–123

Article  PubMed  Google Scholar 

Brandsch M (2013) Drug transport via the intestinal peptide transporter PepT1. Curr Opin Pharmacol 13(6):881–887

Article  PubMed  Google Scholar 

Brayden DJ, Hill T, Fairlie D, Maher S, Mrsny RJ (2020) Systemic delivery of peptides by the oral route: formulation and medicinal chemistry approaches. Adv Drug Deliv Rev 157:2–36

Article  PubMed  Google Scholar 

Brown TD, Whitehead KA, Mitragotri S (2020) Materials for oral delivery of proteins and peptides. Nat Reviews Mater 5(2):127–148

Article  Google Scholar 

Bruno BJ, Miller GD, Lim CS (2013) Basics and recent advances in peptide and protein drug delivery. Therapeutic Delivery 4(11):1443–1467

Article  PubMed  Google Scholar 

Bryniarski MA, Ren T, Rizvi AR, Snyder AM, Morris ME (2020) Targeting the choroid plexuses for protein drug delivery. Pharmaceutics 12(10):963

Article  PubMed  PubMed Central  Google Scholar 

Buckton LK, Rahimi MN, McAlpine SR (2021) Cyclic peptides as drugs for intracellular targets: the next frontier in peptide therapeutic development. Curr Opin Chem Biol 27(5):1487–1513

Google Scholar 

Bumbaca B, Li Z, Shah DK (2019) Pharmacokinetics of protein and peptide conjugates. Drug Metab Pharmacokinet 34(1):42–54

Article  PubMed  Google Scholar 

Bunker A, Magarkar A, Viitala T (2016) Rational design of liposomal drug delivery systems, a review: combined experimental and computational studies of lipid membranes, liposomes and their pegylation. Biochim Et Biophys Acta (BBA) – Biomembr 1858(10):2334–2352

Article  Google Scholar 

Cao S-j, Xu S, Wang H-m, Ling Y, Dong J, Xia R-d, Sun X-H (2019) Nanoparticles: oral delivery for protein and peptide drugs. Asian J Pharm 20:1–11

Google Scholar 

Chaturvedi K, Ganguly K, Kulkarni AR, Rudzinski WE, Krauss L, Nadagouda MN, Aminabhavi TM (2015) Oral insulin delivery using deoxycholic acid conjugated pegylated polyhydroxybutyrate co-polymeric nanoparticles. J Nanopart 10(10):1569–1583

Google Scholar 

Chatzidaki MD, Mitsou E (2025) Advancements in nanoemulsion-based drug delivery across different administration routes. Pharmaceutics 17(3):337

Article  PubMed  PubMed Central  Google Scholar 

Cho H, Huh KM, Cho HJ, Kim B, Shim MS, Cho YY, Kang HC (2024) Beyond nanoparticle-based oral drug delivery: transporter-mediated absorption and disease targeting. Biomaterials Sci 12(12):3045–3067

Article  Google Scholar 

Choonara BF, Choonara YE, Kumar P, Bijukumar D, du Toit LC, Pillay V (2014) A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. Biotechnol Adv 32(7):1269–1282

Article  PubMed  Google Scholar 

Clardy-James S, Allis DG, Fairchild TJ, Doyle RP (2012) Examining the effects of vitamin B 12 conjugation on the biological activity of insulin: a molecular dynamic and in vivo oral uptake investigation. Mol Pharm 3(9):1054–1058

Google Scholar 

Claro B, Bastos M, Garcia-Fandino R (2018) Design and applications of Cyclic peptides. In: Garcia-Fandiño R, Bastos M (eds) Peptide applications in biomedicine, biotechnology and bioengineering. Elsevier, pp 87–129

Cooper BM, Iegre J, O’Donovan DH, Halvarsson MÖ, Spring DR (2021) Peptides as a platform for targeted therapeutics for cancer: Peptide–drug conjugates (PDCs). Chem Soc Rev 50(3):1480–1494

Article  PubMed  Google Scholar 

Costa L, Sousa E, Fernandes C (2023) Cyclic peptides in pipeline: what future for these great molecules? Pharmaceutics 16(7):996

Article  Google Scholar 

Cui J, Wen Z, Zhang W, Wu W (2022) Recent advances in oral peptide or protein-based drug liposomes. Pharmaceutics 15(9):1072

Article  Google Scholar 

Dahlgren D, Sjöblom M, Hedeland M, Lennernäs H (2020) The in vivo effect of transcellular permeation enhancers on the intestinal permeability of two peptide drugs Enalaprilat and hexarelin. Pharmaceutics. 12(2):99

Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A (2016) Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol 44(1):381–391

Article  PubMed  Google Scholar 

Das S, Chaudhury A (2011) Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 12(1):62–76

Article  PubMed  Google Scholar 

D